Skip to main content
. 2019 Apr 17;9:6212. doi: 10.1038/s41598-019-42707-8

Figure 2.

Figure 2

Lgr5+ specific-deletion of PKM2 accelerates development of inflammation-induced CRC. (a) Treatment scheme for AOM/DSS colon cancer model. PKM2f/fxLgr5CreERT2 mice were injected with vehicle (Veh) or tamoxifen (Tx) following induction of colon cancer by treatment of AOM and DSS. (b) Weight loss (n = 32) and (c) representative images of colons from AOM/DSS-treated PKM2ΔLgr5 mice. (d) Tumor load (n = 17 for Veh, n = 18 for Tx) and tumor size (n = 15 for Veh, n = 17 for Tx) in AOM/DSS-treated mice. (e) Colon histology of AOM/DSS-treated mice. Arrowheads indicate colon polyps. Representative images of low- and high-grade dysplasia and adenocarcinoma. Scale bar = 100 μm. H&E stained sections were scored for severity and area of dysplasia (n = 4 for Veh, n = 6 for Tx). All data are mean ± s.e.m. Statistical analyses were done by Student’s t-test or two-way ANOVA with Bonferroni post-hoc test. *p < 0.05, **p < 0.01.